Blister pack with dollars instead of pills Employers are rightfully concerned about the ever-growing cost of prescription drugs, but they typically lack the data visibility and tools to do much about it. (Photo: Shutterstock)

More than ever, the push for greater transparency in prescription drug prices and lowering prescription costs for consumers and plan sponsors is gaining ground in Washington. It’s encouraging to see traction at the federal policy level, given that trendlines are leading to an unsustainable cost situation for American consumers and businesses.

Recent data show prescription drug price increases are outpacing inflation, with prices of some of the most widely used brand-name drugs rising twice as fast as overall inflation. This has a real, dollars-and-cents impact. Today 1 in 4 people in the U.S. have difficulty affording their medications. And employers — who are often challenged to understand their prescription drug spend — report significant concern about sharply rising pharmacy costs.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.